Recommendations of the French Society for Rheumatology regarding TNFα antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update-Reference-Cited by-同舟云学术

Recommendations of the French Society for Rheumatology regarding TNFα antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update

Published:2007-12 Issue:6 Volume:74 Page:638-646
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Pham Thao,Fautrel Bruno,Dernis Emmanuelle,Goupille Philippe,Guillemin Francis,Le Loët Xavier,Ravaud Philippe,Claudepierre Pascal,Miceli-Richard Corinne,de Bandt Michel,Breban Maxime,Maillefert Jean-Francis,Masson Charles,Saraux Alain,Schaeverbeke Thierry,Wendling Daniel,Mariette Xavier,Combe Bernard

Publisher

Elsevier BV

Subject

Rheumatology

Reference56 articles.

1. TNFalpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for Rheumatology;Pham;Joint Bone Spine,2006

2. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated?;Shekelle;JAMA,2001

3. Les recommandations pour la pratique clinique;ANAES;Bases de la méthodologie pour leur réalisation en France,1999

4. When should clinical guidelines be updated?;Shekelle;BMJ,2001

5. Clinical guidelines: developing guidelines;Shekelle;BMJ,1999

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Les recommandations pour l’utilisation des anti-TNF au cours des spondyloarthrites axiales sont-elles pertinentes pour les formes non radiographiques ?;Revue du Rhumatisme;2021-03

2. Are the recommendations for the use of anti-TNF drugs during axial spondyloarthritis relevant for non-radiographic forms?;Joint Bone Spine;2020-10

3. Effectiveness, safety and drug survival of tumor necrosis factor-α inhibitors in the treatment of spondyloarthritis: A real-life study in Tunisia;The Egyptian Rheumatologist;2018-10

4. Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates;Cost Effectiveness and Resource Allocation;2017-09-07

5. Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis;Arthritis & Rheumatology;2016-11-28